Johnson & Johnson will separate consumer products business into new company

Johnson & Johnson said Friday that it will separate its consumer products business from its pharmaceuticals and medical devices division over the next two years as part of an effort to better serve the needs of its patients and customers. The spinoff of notable brands like Tylenol, Benadryl and Listerine is expected to be completed within the next 18-24 months. After the separation, Johnson & Johnson said it will continue to focus on developing life-saving treatments and surgical tools.



Source link